Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. cell genomics
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Books
Downloads
Videos

Refine by
Date

  • Older

Cell Genomics Articles & Analysis

38 news found

Addressing The Issue Of Genomic Stability In IPSCs: New Approach For Restoring Cell Lines, Upcoming Webinar Hosted By Xtalks

Addressing The Issue Of Genomic Stability In IPSCs: New Approach For Restoring Cell Lines, Upcoming Webinar Hosted By Xtalks

The featured speakers will explore the different types of quality control (QC) required for iPSCs with a focus on genomic stability assessment. Stem cells have revolutionized cell-based therapeutics, drug discovery and many other scientific fields. ...

ByArtel, Inc. by Advanced Instruments


CD Genomics Unveils Cutting-Edge 5mC/5hmC Sequencing Service to Drive Epigenomics Research Forward

CD Genomics Unveils Cutting-Edge 5mC/5hmC Sequencing Service to Drive Epigenomics Research Forward

A comprehensive understanding of the distribution and dynamic changes in 5mC and 5hmC is of paramount importance when unraveling processes such as tumorigenesis, neurodevelopment, and stem cell differentiation. The 5mC/5hmC sequencing service by CD Genomics is designed to be a highly dependable tool for precisely identifying the location and extent of these ...

ByCD Genomics


CD Genomics Redefines Genomic Research with Full-Length Transcripts Sequencing (Iso-Seq)

CD Genomics Redefines Genomic Research with Full-Length Transcripts Sequencing (Iso-Seq)

CD Genomics, a leading provider of genomic solutions, has announced a groundbreaking development in genomic research with the introduction of their Full-Length Transcripts Sequencing (Iso-Seq) technology. ...

ByCD Genomics


CD BioGlyco Announced Service for Analysis of Glycolytic Enzymes in Cancer Cells

CD BioGlyco Announced Service for Analysis of Glycolytic Enzymes in Cancer Cells

CD BioGlyco, a biotechnology company that provides multi-omics analysis of cancer cell glycolysis including genomics, proteomics, metabolomics and metabolic fluxomics, now offers analysis of glycolytic enzymes in cancer cells, enabling thorough understanding of cancer cell glycolysis pathways. The capacity of cancer ...

ByCD BioGlyco.


CD Genomics Longseq Division Unveils Human Leukocyte Antigen (HLA) Typing Service

CD Genomics Longseq Division Unveils Human Leukocyte Antigen (HLA) Typing Service

The HLA gene products can be expressed on different cell surfaces and play critical roles in antigen presentation and immune signaling. ...

ByCD Genomics


CytoRecovery Awarded National Science Foundation Phase II SBIR Research Grant

CytoRecovery Awarded National Science Foundation Phase II SBIR Research Grant

She added, “As medicine moves towards personalized care, more precise cell recovery is required for research and pharmaceutical development, especially in the new fields of cell therapeutics and genomics. To address this challenge, we have brought to market our CytoR1 Platform - a label-free, fully-integrated product system for ...

ByCytorecovery, Inc.


Circulating Tumor Cell detection by Menarini Group’s CELLSEARCH System leading to genomic profiling of myeloma cells shows potential for non-invasive management of Multiple Myeloma patients at early stages of disease

Circulating Tumor Cell detection by Menarini Group’s CELLSEARCH System leading to genomic profiling of myeloma cells shows potential for non-invasive management of Multiple Myeloma patients at early stages of disease

Researchers at Dana-Farber Cancer Institute showed that enumeration of circulating tumor cells (CTCs) with Menarini Silicon Biosystems’ CELLSEARCH® System and the CELLSERCH® Circulating Multiple Myeloma Cell (CMMC) Test* can be used to monitor and manage patients with Multiple Myeloma (MM) even at asymptomatic precursor stages Menarini Silicon ...

ByThe Menarini Group


Cellworks Therapy Biosimulation Study Reveals Promising New Biomarkers for TMZ Resistance in Glioblastoma Patients

Cellworks Therapy Biosimulation Study Reveals Promising New Biomarkers for TMZ Resistance in Glioblastoma Patients

” Cellworks Therapy Biosimulation The Cellworks Platform biosimulates how a patient's personalized genomic disease model will respond to therapies prior to treatment and can also identify novel drug combinations for treatment-refractory patients. ...

ByCellworks Research India Private Limited


CD Genomics to Present at BIO International Convention 2022

CD Genomics to Present at BIO International Convention 2022

CD Genomics, a world-leading genomics services company, today announced that members of its management team will participate in the BIO International Convention on June 13-16th, 2022, in San Diego, California. ...

ByCD Genomics


Creative Enzymes to Present at the BIO International Convention on June 13-16th, 2022

Creative Enzymes to Present at the BIO International Convention on June 13-16th, 2022

BIO brings together a wide spectrum of life science and applications, including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology, and cell therapy. Date: June 13-16th, 2022 Location: San Diego, California Registration: https://www.bio.org/events/bio-international-convention/registration Creative Enzymes is glad to be finally physically ...

ByCreative Enzymes


Berkeley Lights to Participate in the 18th Annual PEGS Boston Conference & Expo

Berkeley Lights to Participate in the 18th Annual PEGS Boston Conference & Expo

(Nasdaq: BLI), a leader in digital cell biology, today announced its participation at the 18th Annual PEGS Boston Conference, a protein engineering and cell therapy summit, being held virtually and in person from May 2-6, 2022 at the Hynes Convention Center. ...

ByBruker Corporation


TreeFrog Therapeutics launches a $100,000 research grant in regenerative medicine

TreeFrog Therapeutics launches a $100,000 research grant in regenerative medicine

TreeFrog Therapeutics, a biotechnology company aimed at making safer, more efficient and more affordable cell therapies based on induced pluripotent stem cells (iPSCs), today announced the launch of The Stem Cell SpaceShot Grant, a $100,000 research funding in the field of stem cell biology and regenerative medicine. The ...

ByTreefrog Therapeutics


CytoRecovery Presents Data at the 2022 American Association for Cancer Research (AACR) Annual Meeting

CytoRecovery Presents Data at the 2022 American Association for Cancer Research (AACR) Annual Meeting

CytoRecovery, Inc., a leader in the marker free enrichment, sorting, and recovery of live cells, presented recent study results at the American Association for Cancer Research (AACR) Annual Meeting 2022 currently being held in New Orleans. The study was completed in collaboration with The Laboratory of Integrative Cancer Immunology, National Cancer Institute (NCI/NIH Bethesda, MD) and Virginia ...

ByCytorecovery, Inc.


Caribou Biosciences Presents Positive Preclinical Data for Allogeneic Anti-BCMA CAR-T Cell Therapy Candidate CB-011 at the American Association for Cancer Research (AACR) Annual Meeting

Caribou Biosciences Presents Positive Preclinical Data for Allogeneic Anti-BCMA CAR-T Cell Therapy Candidate CB-011 at the American Association for Cancer Research (AACR) Annual Meeting

” Details of the poster presentation are as follows: Title: A BCMA-specific allogeneic CAR-T cell therapy (CB-011) genome engineered to express an HLA-E fusion transgene to prevent immune cell rejection Presenter: Émilie Degagné, Ph.D. ...

ByCaribou Biosciences, Inc.


Profacgen Launched Antibiotic-free Expression System for Protein Expression Service

Profacgen Launched Antibiotic-free Expression System for Protein Expression Service

The system is based on two genes, a toxin gene that can cause cell death is inserted into the genome of the expressing strain. Antitoxin genes are located in expression plasmids, and antitoxins act as toxin inhibitors. ...

ByProfacgen


Stem Pharm welcomes their newest Advisor, Dr. Edsel Abud

Stem Pharm welcomes their newest Advisor, Dr. Edsel Abud

Abud notably developed one of the first methods to generate human microglia from stem cells, showing their functional genomics and how they play a role in health and disease. ...

ByStem Pharm, Inc


Immunai Raises $215 Million to Accelerate Development of Its Immune-First Drug Actuary Platform

Immunai Raises $215 Million to Accelerate Development of Its Immune-First Drug Actuary Platform

Our approach is to combine best-in-class single-cell genomic methods and artificial intelligence with a deep understanding of immunology.” Immunai has leveraged its best-in-class proprietary technologies and more than 25 academic partnerships to build AMICA™, the Annotated Multiomic Immune Cell Atlas, the world’s largest data ...

ByImmunai


Molecular Health and Gen Era Diagnostics agree to collaborate in the field of precision oncology in Turkey

Molecular Health and Gen Era Diagnostics agree to collaborate in the field of precision oncology in Turkey

In addition, the company offers services for the life sciences, including genomics, proteomics, and cell analyses. “With MH Guide, doctors can manage the flood of data from molecular genetic testing and translate it into targeted therapy recommendations. ...

ByMolecular Health GmbH


Dr. Jeanne Loring Joins StemBioSys Scientific Advisory Board; World-renowned leader in Stem Cell Biology

Dr. Jeanne Loring Joins StemBioSys Scientific Advisory Board; World-renowned leader in Stem Cell Biology

Among the many accomplishments of her career, she has led hallmark research studies on differentiating human induced pluripotent stem cells (iPSCs) into neurons that have important applications in treating neurological ...

ByStemBioSys, Inc.


Data Driven: Immunai Adds Biocuration, European Hubs with Nebion Acquisition

Data Driven: Immunai Adds Biocuration, European Hubs with Nebion Acquisition

AMICA is a downloadable database of annotated multi-omic immune cells that includes information about gene expression, proteins, T-cell and B-cell receptors for immune cells, clinical and/or lab data, and a downloadable artificial intelligence software platform designed for characterizing and analyzing immune ...

ByImmunai

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT